Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Tao Q, Murty VV.

Genes Chromosomes Cancer. 2009 Nov;48(11):983-92. doi: 10.1002/gcc.20703.

PMID:
19681120
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.

Li Z, Li W, Xie J, Wang Y, Tang A, Li X, Ye J, Gui Y, Cai Z.

Cell Biol Int. 2011 Jul;35(7):671-6. doi: 10.1042/CBI20100568.

PMID:
21314642
[PubMed - indexed for MEDLINE]
3.

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression.

Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B, Murty VV.

Mol Cancer. 2006 May 15;5:16.

PMID:
16700909
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Role of PCDH10 and its hypermethylation in human gastric cancer.

Li Z, Chim JC, Yang M, Ye J, Wong BC, Qiao L.

Biochim Biophys Acta. 2012 Feb;1823(2):298-305. doi: 10.1016/j.bbamcr.2011.11.011. Epub 2011 Dec 20.

PMID:
22206871
[PubMed - indexed for MEDLINE]
Free Article
5.

Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings.

Wang KH, Liu HW, Lin SR, Ding DC, Chu TY.

Cancer Sci. 2009 Nov;100(11):2175-80. doi: 10.1111/j.1349-7006.2009.01285.x. Epub 2009 Jul 17.

PMID:
19709077
[PubMed - indexed for MEDLINE]
6.

Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.

Narayan G, Freddy AJ, Xie D, Liyanage H, Clark L, Kisselev S, Un Kang J, Nandula SV, McGuinn C, Subramaniyam S, Alobeid B, Satwani P, Savage D, Bhagat G, Murty VV.

Genes Chromosomes Cancer. 2011 Dec;50(12):1043-53. doi: 10.1002/gcc.20922. Epub 2011 Aug 24.

PMID:
21960365
[PubMed - indexed for MEDLINE]
7.

PCDH10 is a candidate tumour suppressor gene in medulloblastoma.

Bertrand KC, Mack SC, Northcott PA, Garzia L, Dubuc A, Pfister SM, Rutka JT, Weiss WA, Taylor MD.

Childs Nerv Syst. 2011 Aug;27(8):1243-9. doi: 10.1007/s00381-011-1486-x. Epub 2011 May 20.

PMID:
21597995
[PubMed - indexed for MEDLINE]
8.

Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.

Zhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, Li J, Rader JS.

Oncogene. 2006 Aug 31;25(39):5436-45. Epub 2006 Apr 10.

PMID:
16607278
[PubMed - indexed for MEDLINE]
9.

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ.

Gastroenterology. 2009 Feb;136(2):640-51.e1. doi: 10.1053/j.gastro.2008.10.050. Epub 2008 Oct 29.

PMID:
19084528
[PubMed - indexed for MEDLINE]
10.

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.

Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Schneider A, Arias-Pulido H, Murty VV.

Mol Cancer. 2008 Jun 17;7:58. doi: 10.1186/1476-4598-7-58.

PMID:
18559093
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma.

Li Y, Yang ZS, Song JJ, Liu Q, Chen JB.

Int J Mol Med. 2012 Apr;29(4):704-10. doi: 10.3892/ijmm.2012.880. Epub 2012 Jan 9.

PMID:
22245948
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

IGSF4 promoter methylation and expression silencing in human cervical cancer.

Li J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS.

Gynecol Oncol. 2005 Jan;96(1):150-8.

PMID:
15589594
[PubMed - indexed for MEDLINE]
13.

Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene.

Singh RK, Indra D, Mitra S, Mondal RK, Basu PS, Roy A, Roychowdhury S, Panda CK.

Hum Genet. 2007 Aug;122(1):71-81. Epub 2007 May 22.

PMID:
17609981
[PubMed - indexed for MEDLINE]
14.

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.

Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV.

Mol Cancer. 2003 May 13;2:24.

PMID:
12773202
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV.

Genes Chromosomes Cancer. 2008 Sep;47(9):755-65. doi: 10.1002/gcc.20577.

PMID:
18506748
[PubMed - indexed for MEDLINE]
16.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

PMID:
17311676
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.

Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ.

Tumori. 2007 Nov-Dec;93(6):572-9.

PMID:
18338492
[PubMed - indexed for MEDLINE]
18.

[Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].

Xu J, Wang HL, Lu GC, Wang ZJ, Lin X, Zhou HW.

Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):394-7. Chinese.

PMID:
17697601
[PubMed - indexed for MEDLINE]
19.

PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.

Narayan G, Xie D, Freddy AJ, Ishdorj G, Do C, Satwani P, Liyanage H, Clark L, Kisselev S, Nandula SV, Scotto L, Alobeid B, Savage D, Tycko B, O'Connor OA, Bhagat G, Murty VV.

Genes Chromosomes Cancer. 2013 Nov;52(11):1030-41. doi: 10.1002/gcc.22098. Epub 2013 Aug 9.

PMID:
23929756
[PubMed - indexed for MEDLINE]
20.

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.

Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, Dürst M, Pothuri B, Murty VV.

Cancer Res. 2004 May 1;64(9):2994-7.

PMID:
15126331
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk